MLN8054 Terminated Phase 1 Trials for Advanced Malignancies Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00652158A Phase 1 Trial of Extended MLN8054 Dosing in Patients With Advanced Malignancies